Global Pneumococcal Vaccine Market Size study, by Vaccine Type by Product by End-use and Regional Forecasts 2022-2032

Description

List of Tables

Global Pneumococcal Vaccine Market is valued approximately USD 8.07 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.21% over the forecast period 2024-2032. The Pneumococcal Vaccine is a vaccine that helps protect against infection by Streptococcus pneumoniae bacteria, also known as pneumococcus. This bacterium can cause various infections, including pneumonia, meningitis, and bacteremia (bloodstream infection). The vaccine works by stimulating the body's immune system to produce antibodies against specific strains of the bacteria, thereby preventing infection. Also, the Global Pneumococcal Vaccine market is experiencing advancements in vaccine technology, such as the development of next-generation conjugate vaccines with enhanced efficacy against a broader range of pneumococcal strains. These advancements contribute to the improvement of vaccine effectiveness and coverage.

Moreover, the rising prevalence of pneumococcal diseases, such as pneumonia, meningitis, and bacteremia, is a significant driver. These diseases impose a considerable burden on healthcare systems worldwide, leading to a higher demand for preventive measures such as vaccines. Also, government initiatives aimed at reducing the burden of infectious diseases play a crucial role. Many countries have implemented vaccination programs targeting infants, children, and adults to prevent pneumococcal infections. Subsidies, reimbursements, and vaccination mandates further boost market growth. Additionally, other factors support the market growth are raising global awareness of pneumonia vaccination programs, and introduction of new vaccines for the prevention of pneumococcal diseases is anticipated to create the lucrative opportunity for the market. However, high manufacturing cost is expected to hinder the market growth during the forecast period 2024-2032.

The key regions considered for the Global Pneumococcal Vaccine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue. Government initiatives, such as vaccination programs for children and the elderly, play a significant role in driving the adoption of pneumococcal vaccines. These programs often provide free or subsidized vaccines, making them more accessible to a larger portion of the population. Also, ongoing research and development efforts have led to the development of more efficacious and advanced pneumococcal vaccines. Newer vaccines offer broader coverage against a greater number of pneumococcal strains, thereby increasing their effectiveness in preventing diseases. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period.

Major market player included in this report are:

Serum Institute of India Pvt. Ltd
CSL Limited
Sanofi SE
GlaxoSmithKline plc
Merck & Co., Inc
Pfizer Inc
Walvax Biotechnology Co., Ltd
Beijing Minhai Biotechnology Co., Ltd
Astellas Pharma Inc
Panacea Biotech Ltd

The detailed segments and sub-segment of the market are explained below:

By Vaccine Type

Pneumococcal Conjugate Vaccine
Pneumococcal Polysaccharide Vaccine

By Product

Prevnar 13
Synflorix
Pneumovax 23
Vaxneuvance
Pneumosil
Other Products

By End-use

Public Sector
Private Sector

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Pneumococcal Vaccine Market Definition and Research Assumptions

1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
- 1.3.1. Inclusion & Exclusion
- 1.3.2. Limitations
- 1.3.3. Supply Side Analysis
  - 1.3.3.1. Availability
  - 1.3.3.2. Infrastructure
  - 1.3.3.3. Regulatory Environment
  - 1.3.3.4. Market Competition
  - 1.3.3.5. Economic Viability (Consumer's Perspective)
- 1.3.4. Demand Side Analysis
  - 1.3.4.1. Regulatory frameworks
  - 1.3.4.2. Technological Advancements
  - 1.3.4.3. Environmental Considerations
  - 1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary

2.1. Global Pneumococcal Vaccine Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
- 2.3.1. By Vaccine Type
- 2.3.2. By Product
- 2.3.3. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Pneumococcal Vaccine Market Dynamics

3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities

Chapter 4. Global Pneumococcal Vaccine Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Pneumococcal Vaccine Market Size & Forecasts by Vaccine Type 2022-2032

5.1. Pneumococcal Conjugate Vaccine
5.2. Pneumococcal Polysaccharide Vaccine

Chapter 6. Global Pneumococcal Vaccine Market Size & Forecasts by Product 2022-2032

6.1. Prevnar 13
6.2. Synflorix
6.3. Pneumovax 23
6.4. Vaxneuvance
6.5. Pneumosil
6.6. Other Products

Chapter 7. Global Pneumococcal Vaccine Market Size & Forecasts by End-use 2022-2032

7.1. Public Sector
7.2. Private Sector

Chapter 8. Global Pneumococcal Vaccine Market Size & Forecasts by Region 2022-2032

8.1. North America Pneumococcal Vaccine Market
- 8.1.1. U.S. Pneumococcal Vaccine Market
  - 8.1.1.1. Vaccine Type breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Product breakdown size & forecasts, 2022-2032
  - 8.1.1.3. End-use breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Pneumococcal Vaccine Market
8.2. Europe Pneumococcal Vaccine Market
- 8.2.1. U.K. Pneumococcal Vaccine Market
- 8.2.2. Germany Pneumococcal Vaccine Market
- 8.2.3. France Pneumococcal Vaccine Market
- 8.2.4. Spain Pneumococcal Vaccine Market
- 8.2.5. Italy Pneumococcal Vaccine Market
- 8.2.6. Rest of Europe Pneumococcal Vaccine Market
8.3. Asia-Pacific Pneumococcal Vaccine Market
- 8.3.1. China Pneumococcal Vaccine Market
- 8.3.2. India Pneumococcal Vaccine Market
- 8.3.3. Japan Pneumococcal Vaccine Market
- 8.3.4. Australia Pneumococcal Vaccine Market
- 8.3.5. South Korea Pneumococcal Vaccine Market
- 8.3.6. Rest of Asia Pacific Pneumococcal Vaccine Market
8.4. Latin America Pneumococcal Vaccine Market
- 8.4.1. Brazil Pneumococcal Vaccine Market
- 8.4.2. Mexico Pneumococcal Vaccine Market
- 8.4.3. Rest of Latin America Pneumococcal Vaccine Market
8.5. Middle East & Africa Pneumococcal Vaccine Market
- 8.5.1. Saudi Arabia Pneumococcal Vaccine Market
- 8.5.2. South Africa Pneumococcal Vaccine Market
- 8.5.3. Rest of Middle East & Africa Pneumococcal Vaccine Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Serum Institute of India Pvt. Ltd.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. CSL Limited
- 9.3.3. Sanofi SE
- 9.3.4. GlaxoSmithKline plc
- 9.3.5. Merck & Co., Inc.
- 9.3.6. Pfizer Inc.
- 9.3.7. Walvax Biotechnology Co., Ltd
- 9.3.8. Beijing Minhai Biotechnology Co., Ltd
- 9.3.9. Astellas Pharma Inc
- 9.3.10. Panacea Biotech Ltd

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes

LIST OF TABLES

TABLE 1. Global Pneumococcal Vaccine market, report scope
TABLE 2. Global Pneumococcal Vaccine market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Pneumococcal Vaccine market estimates & forecasts by Vaccine Type 2022-2032 (USD Billion)
TABLE 4. Global Pneumococcal Vaccine market estimates & forecasts by Product 2022-2032 (USD Billion)
TABLE 5. Global Pneumococcal Vaccine market estimates & forecasts by End-use 2022-2032 (USD Billion)
TABLE 6. Global Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Pneumococcal Vaccine market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Pneumococcal Vaccine market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Pneumococcal Vaccine market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Pneumococcal Vaccine market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Pneumococcal Vaccine market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. Global Pneumococcal Vaccine market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 17. U.S. Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. U.S. Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 19. Canada Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 20. Canada Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 21. Canada Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 22. UK Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 23. UK Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 24. UK Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 25. Germany Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 26. Germany Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 27. Germany Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 28. France Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 29. France Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 30. France Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 31. Italy Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 32. Italy Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 33. Italy Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 34. Spain Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 35. Spain Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 36. Spain Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 37. RoE Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 38. RoE Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 39. RoE Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 40. China Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 41. China Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 42. China Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 43. India Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 44. India Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 45. India Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 46. Japan Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 47. Japan Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 48. Japan Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 49. Australia Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 50. Australia Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 51. Australia Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 52. South Korea Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 53. South Korea Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 54. South Korea Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 55.
TABLE 56. RoAPAC Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 57. RoAPAC Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 58. RoAPAC Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 59. Brazil Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 60. Brazil Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 61. Brazil Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 62. Mexico Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 63. Mexico Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 64. Mexico Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 65. RoLA Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 66. RoLA Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 67. RoLA Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 68. Saudi Arabia Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 69. Saudi Arabia Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 70. Saudi Arabia Pneumococcal Vaccine market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 71. South Africa Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 72.
TABLE 73. South Africa Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 74. South Africa Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 75. RoMEA Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 76. RoMEA Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 77. RoMEA Pneumococcal Vaccine market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 78. List of secondary sources, used in the study of Global Pneumococcal Vaccine Market.
TABLE 79. List of primary sources, used in the study of Global Pneumococcal Vaccine Market.
TABLE 80. Years considered for the study.
TABLE 81. Exchange rates considered

LIST OF FIGURES

FIG 1. Global Pneumococcal Vaccine market, research methodology
FIG 2. Global Pneumococcal Vaccine market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Pneumococcal Vaccine market, key trends 2023
FIG 5. Global Pneumococcal Vaccine market, growth prospects 2022-2032
FIG 6. Global Pneumococcal Vaccine market, porters 5 force model
FIG 7. Global Pneumococcal Vaccine market, pestel analysis
FIG 8. Global Pneumococcal Vaccine market, value chain analysis
FIG 9. Global Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Pneumococcal Vaccine market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Pneumococcal Vaccine market, regional snapshot 2022 & 2032
FIG 15. North America Pneumococcal Vaccine market 2022 & 2032 (USD Billion)
FIG 16. Europe Pneumococcal Vaccine market 2022 & 2032 (USD Billion)
FIG 17. Asia pacific Pneumococcal Vaccine market 2022 & 2032 (USD Billion)
FIG 18. Latin America Pneumococcal Vaccine market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Pneumococcal Vaccine market 2022 & 2032 (USD Billion)
FIG 20. Global Pneumococcal Vaccine market, company market share analysis (2023)